Routine Screening of Strongyloides Among Patients With Lymphoma and Efficacy of Targeted Prophylaxis.

IF 10.1 1区医学 Q1 HEMATOLOGY

American Journal of Hematology Pub Date : 2025-05-19 DOI:10.1002/ajh.27719

Michele D Stanchina,Camila Sacher,Yamila Melendez,Pamela Dudkiewicz,Jose F Camargo,Izidore S Lossos

引用次数: 0

Abstract

A total of 1372 lymphoma patients (980 newly diagnosed and 392 seen in cellular therapy clinic) were screened for Strongyloides serology, detecting IgG in 80 (6%) patients. Only one out of 80 (1.25%) patients diagnosed and treated with ivermectin for Strongyloides developed disseminated strongyloidiasis following chemotherapy treatments, supporting routine screening and prophylaxis in lymphoma patients.

查看原文本刊更多论文

淋巴瘤患者类圆线虫的常规筛查及针对性预防的效果。

对1372例淋巴瘤患者（其中980例为新诊断，392例为细胞治疗门诊）进行了类圆线虫血清学筛查，其中80例（6%）检测到IgG。经伊维菌素诊断和治疗的80例类圆线虫患者中，只有1例（1.25%）在化疗后发生弥散性类圆线虫病，这支持了淋巴瘤患者的常规筛查和预防。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

American Journal of Hematology 医学-血液学

CiteScore

15.70

自引率

3.90%

发文量

363

审稿时长

3-6 weeks

期刊介绍： The American Journal of Hematology offers extensive coverage of experimental and clinical aspects of blood diseases in humans and animal models. The journal publishes original contributions in both non-malignant and malignant hematological diseases, encompassing clinical and basic studies in areas such as hemostasis, thrombosis, immunology, blood banking, and stem cell biology. Clinical translational reports highlighting innovative therapeutic approaches for the diagnosis and treatment of hematological diseases are actively encouraged.The American Journal of Hematology features regular original laboratory and clinical research articles, brief research reports, critical reviews, images in hematology, as well as letters and correspondence.